Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2005
09/14/2005CN1666738A Medicine for treating M2 type acute myelogenous leukemia and preparation method of injection thereof
09/14/2005CN1666737A Application of citric acid solution in preparation of antiphlogistic drug
09/14/2005CN1666736A Compound Tramadol Hydrochoride dispersible Tablet
09/14/2005CN1666724A Drug-carrying intrauterine device without holding bracket made of nanometer composite material
09/14/2005CN1218983C Folic acid-polydiol compound and its medicinal composition
09/14/2005CN1218965C Sodium alginate sulfuric ester and preparation method and use thereof
09/14/2005CN1218964C Urushi polysaccharide sulfation and its preparation method and uses
09/14/2005CN1218955C Pregnanedione compound, preparation method and use
09/14/2005CN1218945C Method for producing lipoic acid and dihydrolipoic acid
09/14/2005CN1218943C 4-pyrimidine-N-acyl-L-phenylalanines compound
09/14/2005CN1218942C Antifibrosis pyridinone compound and its preparing process
09/14/2005CN1218941C Process for preparing ethyl-sulfonylpiperidine derivatives
09/14/2005CN1218940C Nitric oxide synthase inhibitors
09/14/2005CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/14/2005CN1218933C Acylhydrazone compound, preparing method and use thereof
09/14/2005CN1218739C Application of Chinese lizardtail herb and its extractive in preventing and treating prostatosis
09/14/2005CN1218736C Fragrance health-care product
09/14/2005CN1218729C Xuerongguyugao ointment for healing fracture and its prepn.
09/14/2005CN1218727C Traditional Chinese medicine composition for cancer
09/14/2005CN1218720C Chinese medicine burn paste and its producing method
09/14/2005CN1218705C Anti SARS virus medicine and synthesizing method thereof
09/14/2005CN1218704C Sodium bialginate for injection and its preparation method
09/14/2005CN1218703C Chitose antibacterial film of uterine neck
09/14/2005CN1218702C Malaria fewer preventing medicinal composition
09/14/2005CN1218701C Use of spirosterol type steroid saponin in preparing medicine for treating cardio-cerebral vascular disease
09/14/2005CN1218700C Usage of sulfonylureas derivant in the preparing process of blood vessel embolism disease treating medicine
09/14/2005CN1218699C Method for increasing solubility of parabuxinidine-D injection
09/14/2005CN1218698C Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis
09/14/2005CN1218697C Pharmaceutical composition for treating or improving arthritis and diet extender
09/14/2005CN1218696C Thermoformable solid pharmaceutical composition for controlled release of perindopril
09/14/2005CN1218695C Anti-platelet medicine and its use
09/14/2005CN1218694C Method for treating endometriosis or infertility, or improving fertility
09/14/2005CN1218692C Film coating
09/14/2005CN1218691C Dual-layer slow releasing tablet of benproperine phosphate
09/14/2005CN1218689C Pharmaceutical compositions containing tobramycin and xanthan gum
09/14/2005CN1218669C Toxin-reducing dehabit preparation of cigarette with health-care function
09/13/2005US6943269 Contrast media for angiography
09/13/2005US6943268 Method for induction of L-selectin shedding
09/13/2005US6943259 Halogenated triptolide derivatives as immunomodulators and anticancer agents
09/13/2005US6943253 6-phenylpyrrolopyrimidinedione derivatives
09/13/2005US6943252 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
09/13/2005US6943251 Preparation of salts of 4-[4-[(1R)-[4-(trifluoromethyl)phenyl]-2-methoxyethyl]-(3S)-methyl-1-piperazinyl]-4-methyl-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]
09/13/2005US6943249 recrystallizing from a polar aprotic solvent (dimethylsulfoxide, dimethylformamide, dimethylacetamide, or N-methylpyrrolidinone) and a cosolvent (acetonitrile, ethanol, methylethyl ketone, isopropyl alcohol, or 1-propanol); myelodysplastic syndrome
09/13/2005US6943246 3′terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof
09/13/2005US6943243 Control of gene expression in eukaryotic cells
09/13/2005US6943239 Antigenic fusionprotein carrying Galα1,3Gal epitopes
09/13/2005US6943199 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders
09/13/2005US6943197 Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses
09/13/2005US6943196 NF-κB inhibitor comprising phenylmethyl benzoquinone as the active ingredient
09/13/2005US6943194 oxidizing 3-(tert-butyl dimethylsilyl)oxy-4-methoxybenzaldehyde with potassium permanganate to form carboxylic acid, converting to corresponding acid chloride, protecting with a butyllithium derivative, deprotecting to form phenstatin
09/13/2005US6943193 administering to the male or femal patients with sexual disorders a therapeutically effective amount of atomoxetine or a pharmaceutically acceptable salt
09/13/2005US6943192 Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
09/13/2005US6943191 dihydroxy or diketoaromatic compounds; protein kinase inhibitors; antiproliferative activity
09/13/2005US6943190 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions
09/13/2005US6943189 mixture of sulfur compounds and 3-hydroxy-3-methylglutaryl-coenzyme A inhibitors, used for prophylaxis of hyperlipemia in mammals
09/13/2005US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease
09/13/2005US6943187 Shampoos for treating alopecia
09/13/2005US6943186 Administering benzopyrazolyl compound for therapy of sepsis
09/13/2005US6943185 Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
09/13/2005US6943184 For therapy of Alzheimer's disease, Parkinson's disease, Pick's disease, Korsakoff s disease cerebral ageing, of mood disorders, of pain and of tobacco withdrawal
09/13/2005US6943183 Antiproliferative agnets; anticancer agents; skin disorders; restenosis
09/13/2005US6943182 Cyclopentabenzofuran derivatives and their use
09/13/2005US6943181 Use of substituted gamma-lactone compounds as pharmaceutical preparations
09/13/2005US6943179 Biurethane derivatives
09/13/2005US6943177 Alpha-lobeline analogs
09/13/2005US6943176 Heterocyclic derivatives
09/13/2005US6943174 6,5-Fused bicyclic heterocycles
09/13/2005US6943173 Treatment of a number of CNS and periphereal disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders.
09/13/2005US6943172 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders
09/13/2005US6943171 For therapy of urological, vascular or pulmonary disorders
09/13/2005US6943168 Calcium channel inhibitors comprising benzhydril spaced from piperazine
09/13/2005US6943166 Carbocyclic secondary amines such as 6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione, used as preferential enzyme inhibitors for prohylaxis of erectile dysfunction
09/13/2005US6943165 Compound and method for the treatment of pain
09/13/2005US6943164 Pharmaceutical solutions of levosimendan
09/13/2005US6943163 7-Alkyl and cycloalkyl-substituted imidazotriazinones
09/13/2005US6943160 Morpholine derivatives as antagonists of orexin receptors
09/13/2005US6943156 3-(5,6,7,8-Tetrahydro-(1,8)naphthyridin-2-yl)-ethoxy)-11H-di-b enzo(1,4)oxazepin-10-yl)-acetic acid; inhibiting bone resorption; vascular restenosis; osteoporosis; angiogenesis inhibitors; diabetic retinopathy; anticarcinogenic agents
09/13/2005US6943155 Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced GI toxicity
09/13/2005US6943027 Contacting a nucleic acid with an organic polycation to produce a condensed nucleic acid, and then combining product with an amphiphilic cationic lipid; increased shelf life and high transfection activity
09/13/2005US6943026 A mixture of first and second nucleic acid constructs, is used for gene therapy, as antitumor agents, antiproliferative agents, suppressed by a wild-type p53 allele in non-tumour cells relative to tumor cells, prodrug activating thymidine kinase
09/13/2005US6943016 incubating a mixture of astrocytes and glial cells from patient surgical resection, culturing, astrocytes joining to the culture vessel, removing the un-attached cells; purification; treating CNS trauma, neurodegenerative disorders
09/13/2005US6943007 Treatment of cancer and AIDS
09/13/2005US6943000 Detection of modulator of enzyme activity; obtain cells, incubate with modulator, monitor adjustment in enzyme activity, adjustment in activity indicates modulator
09/13/2005US6942986 Detecting inducer in sample; obtain sample, incubate with bacterial extract, measure light generated by bacteria,
09/13/2005US6942982 FEBP1 protein vector host cells and method for making FEBP1 protein
09/13/2005US6942979 Method for screening substances capable of modulating the activity of a TRAAK potassium channel
09/13/2005US6942966 Methods for processing chemical compounds having reactive functional groups
09/13/2005US6942882 Avocado plant extracts
09/13/2005US6942877 Method for producing antibiotic composites
09/13/2005US6942876 Mixture of n-methyl-d-aspartate and nonsteroid antiinflammatory drug
09/13/2005US6942875 Applying polymerizable monomer and fungicide; applying to skins
09/13/2005US6942870 For prevention of photodamage skin, for topical application
09/13/2005US6942868 Aerodynamically light particles for pulmonary drug delivery
09/13/2005US6942861 Functional bacterial protein, intimin, and its use as an antigen for protecting against infection by or transmission of bacteria expressing intimin-like proteins, such as certain pathogenic strains of Escherichial coli
09/13/2005US6942858 Compositions containing bacteriophages and methods of using bacteriophages to treat infections
09/13/2005US6942856 Glycoprotein matrix compositions and methods related thereto
09/13/2005US6942663 Reducing the amount of radiation required to destroy a blood vessel, by injecting a hyperosmotic agent glycerol to the blood vessel to slow down the blood flow, increasing light transmission; treating stomach ulcer
09/13/2005US6941948 Medicament storage and delivery devices
09/13/2005CA2469019C Pharmaceutical composition comprising a 5ht1 receptor agonist
09/13/2005CA2426703C Therapeutic agents and methods of use thereof for the modulation of angiogenesis